Likewise, α-TREM-1 increased ROS production (Figure 6F) and LPS-induced CD177, IL22, and TNFA expression in neutrophils from IBD patients (Supplementary Figure 10E). The gene discussed is IL22; the disease is inflammatory bowel disease.